FOLLACCHIO, GIULIA ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.631
EU - Europa 552
AS - Asia 286
AF - Africa 14
SA - Sud America 4
OC - Oceania 1
Totale 2.488
Nazione #
US - Stati Uniti d'America 1.589
IT - Italia 231
SE - Svezia 127
IN - India 106
SG - Singapore 88
CN - Cina 82
DE - Germania 48
CA - Canada 39
FI - Finlandia 33
RO - Romania 21
BG - Bulgaria 18
IE - Irlanda 16
GB - Regno Unito 13
FR - Francia 12
BE - Belgio 10
TR - Turchia 7
UA - Ucraina 7
PL - Polonia 6
ZA - Sudafrica 6
TG - Togo 5
NL - Olanda 4
AR - Argentina 2
CL - Cile 2
ES - Italia 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
CR - Costa Rica 1
GE - Georgia 1
HK - Hong Kong 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 2.488
Città #
Fairfield 228
Chandler 141
Ashburn 120
Rome 103
Wilmington 95
Houston 87
Seattle 86
Dearborn 84
Woodbridge 83
Cambridge 61
Princeton 61
Ann Arbor 51
Beijing 42
Lawrence 39
New York 36
Plano 36
Singapore 30
Boston 29
Helsinki 29
Millbury 27
Bremen 26
San Paolo di Civitate 26
Ottawa 20
Sofia 18
Dublin 16
Redmond 14
Andover 13
San Diego 13
Toronto 12
Brussels 10
Des Moines 9
Norwalk 9
Nanjing 8
Istanbul 7
Latina 7
Redwood City 7
Fremont 6
Hefei 6
London 6
Hyderabad 5
Lomé 5
Falls Church 4
Hebei 4
Horia 4
Muizenberg 4
Pune 4
San Giorgio A Cremano 4
Terni 4
Abbecourt 3
Buffalo 3
Cologne 3
Fuzhou 3
Warsaw 3
Bühl 2
Federal 2
Guangzhou 2
Kaunas 2
Kunming 2
Leeds 2
Mannheim 2
Milan 2
Monte Porzio Catone 2
Montréal 2
Munich 2
Nanchang 2
Paris 2
Phoenix 2
Pomezia 2
Silverton 2
Valencia 2
Wuhan 2
Atlanta 1
Baotou 1
Bari 1
Barletta 1
Bolzano Vicentino 1
Bonndorf 1
Cattolica 1
Chaoyang 1
Chengdu 1
Civitavecchia 1
Dallas 1
Ferentino 1
Fiano Romano 1
Forlì 1
Gunzenhausen 1
Heidelberg 1
Hounslow 1
Indiana 1
Isernia 1
Jacksonville 1
Jinan 1
L'aquila 1
Lagos 1
Laurel 1
Lishui 1
Longueuil 1
Los Angeles 1
Marino 1
Mexico 1
Totale 1.819
Nome #
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride 131
A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer. A pilot study 119
99mTc-labeled white blood cell scan as a guide to open biopsy in the management of hip and knee prosthesis infection: preliminary results 113
223Ra-dichloride therapy in an elderly bone metastatic castration-resistant prostate cancer patient: a case report presentation and comparison with existing literature 110
A challenging case of tumor-induced osteomalacia: pathophysiological and clinical implications 105
Prostate-specific antigen flare phenomenon during 223Ra-Dichloride treatment for bone metastatic castration-resistant prostate cancer: a case report 96
Why SLNB procedure is not currently used in early stage oral squamous cell carcinoma? 86
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: efficacy and safety in clinical practice 82
Unilateral condylar hyperplasia recurrence after orthognathic surgery: a case report 79
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration‐resistant prostate cancer treated with 223Radium 78
Radiopharmaceuticals labelled with copper radionuclides: clinical results in human beings 77
Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor 77
Radio-localization of non-palpable breast lesions under ultrasonographic guidance: current status and future perspectives 70
Use of 123I-MIBG SPECT in association with 123I-FP-CIT in patients with Early Parkinson’s Disease: a new point of view. 63
Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium. 63
Lymphoscintigraphy for the evaluation of limb lymphatic flow disorders: report of technical procedural standards from an Italian Nuclear Medicine expert panel [Linfogammagrafía para la evaluación de trastornos del flujo linfático de las extremidades: informe de estándares de procedimientos técnicos de un panel de expertos de medicina nuclear italiano] 62
Nuclear medicine procedures in neuroblastoma 62
In vivo microbial targeting of 99mTc-Labeled Human β-Defensin-3 in a rat model of infection 62
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with223Radium-dichloride 54
123I-MIBG scan in decision making of ICD implantation in heart failure patients: a single center experience 53
Ra-223 dichloride management in a nuclear medicine unit: experience of a referral institution 51
HMGB1 expression in leukocytes as a marker of cellular stress induced by 99mTc-HMPAO-labelling procedure: a pilot study 47
Initial experience on clinical relevance of cardiac 123I-MIBG study in heart failure patients 47
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: a quality control study 44
Functional lung volume mapping with perfusional 99mTc-MAA SPECT for radiotherapy planning in patients with locally advanced NSCLC 43
223Radium: analysis of effect of treatment in bone oligo-metastatic CRPC patients 41
In vivo imaging of infection with 99mTc-Labelled Human Beta-Defensin-3 in a Rat Model 39
Long-term chronic suppressive antibiotic therapy (CSAT) in chronic joint infection evaluated by (99m)Tc-HMPAO radiolabeled leucocytes scintigraphy (LS) 37
Analysis of Clinical parameters for the outcame prediction of mCRPC patients treated with Ra-223-dichloride 37
Effectiveness of long-term chronic suppressive antibiotic therapy in chronic joint infection: follow-up by 99mTc-HMPAO-labeled leukocyte scan 36
Role of tALP and ECOG Performance Status in predicting survival in mCRPC patients receiving 223Ra-dichloride 36
Functional lung volume mapping with perfusion SPECT scan for radiotherapy planning in patients with locally advanced NSCLC 36
BEST POSTER AWARD, riconoscimento come Miglior Poster al Congresso Europeo di Cardiologia (ESC), Londra. Titolo: Clinical role of adrenergic septal activity as imaged by 123I-MIBG heart scan in HF patients. Topic: Scintigraphy (SPECT) 34
Lesions dosimetry for 223Ra therapy of bone metastases from castration-resistant prostate cancer 34
Lesion dosimetry for Ra-223 therapy of bone metastases from castration-resistant prostate cancer: patients eligibility criterion and update of dosimetric assessments 33
Rare paranganglioma localizations caught by MRI and CT hybrid 123I-MIBG SPECT imaging. 33
Definition of a Predictive Score to guide therapeutic management in metastatic CRPC patients eligible to Radium-223 32
Clinical role of adrenergic septal activity as imaged by 123-I MIBG heart scan in HF patients 31
Feasibility of 223 Ra imaging for clinical purpose 31
Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC)undergoing 223Ra-dichloride Therapy 30
Radium-223 in metastatic castration-resistant prostate cancer (mCRPC):efficacy and safety in real-life experience 28
Rest/Stress vs. Stress only Myocardial Perfusion Imaging. How many exams could be avoided? Our experience 28
A new diagnostic approach in non-palpable breast cancer and Sentinel Node localization (SNOLL technique) 28
Pain Response and Acute Hematologic Toxicity in Castration-Resistant Prostate Cancer (CRPC) patients (pts) treated with Ra-223-dichloride: a Single-Center Clinical Series 27
Feasibility of 223Ra quantitative imaging for lesion dosimetry 27
Role of psychological status related to pain outcome and bone lesion dosimetry in patients with bone metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with 223Radium 27
Sentinel node biopsy with dual intracervical injection in low-risk, early stage endometrial cancer: preliminary results 27
Proposal for a standardized method to evaluate 123I-MIBGSPECT in HF patients: importance in decision making of ICD implantation. 26
Combined Peptide Radio-Receptor Therapy (PRRT) And Liver Selective Internal Radiation Therapy (SIRT) In Patients With Metastatic Neuroendocrine Tumors: Which Is The Best Sequence? 25
Feasibility of radioguided surgical nodal staging with Tc- EDDA/HYNIC-TOC (Tektrotyd®) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs): a pilot study 24
Use of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) for Radioguided Surgery of Gastroenteropancreatic Neuroendocrine Tumors: A Feasibility Study 22
Mixed leukocytes separation for scintigraphic purposes: assessment of red blood cells contamination 21
Totale 2.704
Categoria #
all - tutte 7.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201969 0 0 0 0 0 0 0 0 0 0 0 69
2019/2020683 59 9 14 25 59 120 130 66 75 63 39 24
2020/2021250 33 14 14 11 3 12 13 10 33 89 12 6
2021/2022480 5 29 32 26 71 19 9 38 34 29 98 90
2022/2023558 117 113 37 76 58 47 11 22 35 10 22 10
2023/2024357 16 48 13 25 53 72 5 39 6 30 27 23
Totale 2.704